Repatha and Initial insomnia - a phase IV clinical study of FDA data

Summary:

Initial insomnia is reported as a side effect among people who take Repatha (evolocumab), especially for people who are female, 60+ old, also take Tylenol, and have Hyperlipidaemia.

The phase IV clinical study analyzes which people have Initial insomnia when taking Repatha. It is created by eHealthMe based on reports of 155,838 people who have side effects when taking Repatha from the FDA, and is updated regularly.

What is Repatha?

Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,228 Repatha users. Check the latest studies of Repatha.

What is Initial insomnia?

Initial insomnia (feeling of inadequate or poor-quality sleep) is found to be associated with 817 drugs and 675 conditions by eHealthMe. Check the latest studies of Initial insomnia.

On Oct, 06, 2025

155,838 people reported to have side effects when taking Repatha.
Among them, 19 people (0.01%) have Initial insomnia.

Among these 19 people:

What is the gender of people who have Initial insomnia when taking Repatha? *

female: 52.63 %
male: 47.37 %

What is the age of people who have Initial insomnia when taking Repatha? *

What are other drugs people take besides Repatha? *

What are other side effects people have besides Initial insomnia? *

Joint Pain: 6 people, 31.58%
Stress And Anxiety: 3 people, 15.79%
Injection Site Reaction: 2 people, 10.53%
The Flu (the flu is caused by an influenza virus): 2 people, 10.53%
Sleep Disorder: 2 people, 10.53%
Blood Cholesterol Decreased: 2 people, 10.53%
Injection Site Bruising: 2 people, 10.53%
Pain In Extremity: 2 people, 10.53%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
Middle Insomnia (difficulty returning to sleep after awakening either in the middle of the night): 2 people, 10.53%

What are the existing conditions these people have? *

Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 15.79%
Pain In Extremity: 2 people, 10.53%
High Blood Pressure: 1 person, 5.26%
Haematuria (presence of blood in urine): 1 person, 5.26%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.26%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Repatha and have Initial insomnia?

- Check whether Initial insomnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Repatha:

Repatha (156,228 reports)

Initial insomnia treatments and more:

Initial insomnia (12,139 reports)

Browse all side effects of Repatha:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Initial insomnia:

Initial insomnia (817 drugs)

Browse all the conditions that are associated with Initial insomnia:

Initial insomnia (675 conditions)

Drugs similar to Repatha and Initial insomnia :

How the study uses the data?

The study uses data from the FDA. It is based on evolocumab (the active ingredients of Repatha) and Repatha (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.